BE study: modified vs immediate release [Design Issues]

posted by BE-proff – 2015-07-28 21:15 (3192 d 15:29 ago) – Posting: # 15165
Views: 6,840

Dear All,

May be my question will seem stupid but nevertheless I ask it.
I have to demonstrate BE between modified release product (taken once a day) and immediate-release product (taken twice a day).
IMHO there is a risk that both product can show different kinetics and they won't be equivalent in 1-time administration of each medications.
To avoid this risk I think of steady state study.

But how to prove my idea based on actual guides?

Does anybody have such experience?

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,658 registered users;
81 visitors (0 registered, 81 guests [including 4 identified bots]).
Forum time: 12:44 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5